Prime Therapeutics Urges Caution On Mandates Of Abuse-Deterrent Formulations Of Opioids Citing Value Concerns Post author:Sam Post published:July 20, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like InfuSystem Holdings, Inc. Announces Amendment To Existing Credit Facility With June 29, 2017 All Signs Have Gilead Gearing Up for a Much-Needed Acquisition February 12, 2017 Once-Prominent Bay Area Biotech VC, Faces Up to 30 Years in Prison September 20, 2017